{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:56:54Z","timestamp":1791579414147,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Methods"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ymeth.2020.02.003","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T11:14:12Z","timestamp":1581506052000},"page":"58-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["From laboratory to clinic: Translation of extracellular vesicle based cancer biomarkers"],"prefix":"10.1016","volume":"177","author":[{"given":"Anudeep","family":"Yekula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koushik","family":"Muralidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko M.","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonora","family":"Balaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob S.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymeth.2020.02.003_b0005","doi-asserted-by":"crossref","first-page":"1438720","DOI":"10.1080\/20013078.2018.1438720","article-title":"Extracellular vesicles: the growth as diagnostics and therapeutics; a survey","volume":"7","author":"Roy","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0010","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/neuonc\/noy074","article-title":"Blood-based biomarkers for the diagnosis and monitoring of gliomas","volume":"20","author":"Zachariah","year":"2018","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.ymeth.2020.02.003_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061349","article-title":"Navigating the landscape of tumor extracellular vesicle heterogeneity","volume":"20","author":"Roy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymeth.2020.02.003_b0020","doi-asserted-by":"crossref","first-page":"1689784","DOI":"10.1080\/20013078.2019.1689784","article-title":"Large and small extracellular vesicles released by glioma cells in vitro and in vivo","volume":"9","author":"Yekula","year":"2020","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0025","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymeth.2020.02.003_b0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40169-018-0192-7","article-title":"Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges","volume":"7","author":"Lane","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ymeth.2020.02.003_b0035","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1158\/1078-0432.CCR-17-3369","article-title":"Exosome-based detection of EGFRT790M in plasma from non-small cell lung cancer patients","volume":"24","author":"Castellanos-Rizaldos","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ymeth.2020.02.003_b0040","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1039\/C8LC01123K","article-title":"Extracellular vesicles as cancer liquid biopsies: from discovery, validation, to clinical application","volume":"19","author":"Zhao","year":"2019","journal-title":"Lab Chip"},{"key":"10.1016\/j.ymeth.2020.02.003_b0045","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fnmol.2017.00276","article-title":"Extracellular vesicles in brain tumors and neurodegenerative diseases","volume":"10","author":"Ciregia","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ymeth.2020.02.003_b0050","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.1967.tb08741.x","article-title":"The nature and significance of platelet products in human plasma","volume":"13","author":"Wolf","year":"1967","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymeth.2020.02.003_b0055","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.23743","article-title":"Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood","volume":"3","author":"Cheng","year":"2014","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0060","doi-asserted-by":"crossref","first-page":"31655","DOI":"10.3402\/jev.v5.31655","article-title":"Comparative analysis of EV isolation procedures for miRNAs detection in serum samples","volume":"5","author":"Andreu","year":"2016","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0065","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/CIRCRESAHA.117.309417","article-title":"Methodological guidelines to study extracellular vesicles","volume":"120","author":"Coumans","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymeth.2020.02.003_b0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/09537104.2012.689038","article-title":"Do blood collection methods influence whole-blood platelet function analysis?","volume":"24","author":"Lanc\u00e9","year":"2013","journal-title":"Platelets"},{"key":"10.1016\/j.ymeth.2020.02.003_b0075","doi-asserted-by":"crossref","first-page":"935","DOI":"10.7326\/0003-4819-140-11-200406010-00027","article-title":"To butterfly or to needle: the pilot phase","volume":"140","author":"Hefler","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ymeth.2020.02.003_b0080","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1160\/TH10-09-0595","article-title":"Pre-analytical and analytical issues in the analysis of blood microparticles","volume":"105","author":"Yuana","year":"2011","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ymeth.2020.02.003_b0085","first-page":"166","article-title":"Interference of heparin with the polymerase chain reaction","volume":"9","author":"Beutler","year":"1990","journal-title":"Biotechniques"},{"key":"10.1016\/j.ymeth.2020.02.003_b0090","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mt.2011.303","article-title":"Microvesicle-associated AAV vector as a novel gene delivery system","volume":"20","author":"Maguire","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymeth.2020.02.003_b0095","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1182\/blood-2011-05-353391","article-title":"Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4\/heparin antibodies","volume":"119","author":"Krauel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ymeth.2020.02.003_b0100","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12207","article-title":"Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop","author":"Lacroix","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymeth.2020.02.003_b0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.thromres.2013.11.010","article-title":"Improved circulating microparticle analysis in acid-citrate dextrose (ACD) anticoagulant tube","volume":"133","author":"Gy\u00f6rgy","year":"2014","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ymeth.2020.02.003_b0110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89631","article-title":"Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients","volume":"1","author":"van Eijndhoven","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ymeth.2020.02.003_b0115","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1538-7836.2011.04610.x","article-title":"Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol: Pre-analytics influence on microparticles analysis","volume":"10","author":"Lacroix","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymeth.2020.02.003_b0120","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1158\/1940-6207.CAPR-11-0370","article-title":"Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies","volume":"5","author":"Pritchard","year":"2012","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.ymeth.2020.02.003_b0125","doi-asserted-by":"crossref","first-page":"20360","DOI":"10.3402\/jev.v2i0.20360","article-title":"Standardization of sample collection, isolation and analysis methods in extracellular vesicle research","volume":"2","author":"Witwer","year":"2013","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0130","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1111\/j.1538-7836.2004.00936.x","article-title":"Measuring circulating cell-derived microparticles","volume":"2","author":"Jy","year":"2004","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ymeth.2020.02.003_b0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jim.2011.10.012","article-title":"Methodology for isolation, identification and characterization of microvesicles in peripheral blood","volume":"375","author":"Jayachandran","year":"2012","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ymeth.2020.02.003_b0140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2006.06167.x","article-title":"Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation","volume":"134","author":"Keuren","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ymeth.2020.02.003_b0145","doi-asserted-by":"crossref","first-page":"14394","DOI":"10.1021\/la2038763","article-title":"Quantitative nanostructural and single-molecule force spectroscopy biomolecular analysis of human-saliva-derived exosomes","volume":"27","author":"Sharma","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.ymeth.2020.02.003_b0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1601-0825.2009.01604.x","article-title":"Exosomes from human saliva as a source of microRNA biomarkers","volume":"16","author":"Michael","year":"2010","journal-title":"Oral Dis."},{"key":"10.1016\/j.ymeth.2020.02.003_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030679","article-title":"The majority of microRNAs detectable in serum and saliva is concentrated in exosomes","volume":"7","author":"Gallo","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymeth.2020.02.003_b0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/epi.12.24","article-title":"Differences in the quantity of DNA found in the urine and saliva of smokers versus nonsmokers: implications for the timing of epigenetic events","volume":"4","author":"Simkin","year":"2012","journal-title":"Epigenomics"},{"key":"10.1016\/j.ymeth.2020.02.003_b0165","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1055\/s-2007-1024720","article-title":"Serum and saliva cortisol responses and blood lactate accumulation during incremental exercise testing","volume":"12","author":"Port","year":"1991","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.ymeth.2020.02.003_b0170","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1258\/000456307780480954","article-title":"Salivary cortisol reflects serum cortisol: analysis of circadian profiles","volume":"44","author":"Dorn","year":"2007","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ymeth.2020.02.003_b0175","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1016\/j.jaci.2004.12.1134","article-title":"Objective monitoring of nasal airway inflammation in rhinitis","volume":"115","author":"Howarth","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ymeth.2020.02.003_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162244","article-title":"Airway secretory microRNAome changes during rhinovirus infection in early childhood","volume":"11","author":"Gutierrez","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymeth.2020.02.003_b0185","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1183\/09031936.03.00072003","article-title":"Biological markers in nasal secretions","volume":"21","author":"Riechelmann","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.ymeth.2020.02.003_b0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12920-019-0473-z","article-title":"Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid","volume":"12","author":"Otake","year":"2019","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.ymeth.2020.02.003_b0195","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1177\/1352458517696597","article-title":"Multiple sclerosis: serum-derived exosomes express myelin proteins","volume":"24","author":"Galazka","year":"2018","journal-title":"Mult. Scler."},{"key":"10.1016\/j.ymeth.2020.02.003_b0200","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1093\/neuonc\/nox085","article-title":"Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients","volume":"19","author":"Figueroa","year":"2017","journal-title":"Neuro. Oncol."},{"key":"10.1016\/j.ymeth.2020.02.003_b0205","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/pcan.2017.7","article-title":"Extracellular vesicles for liquid biopsy in prostate cancer: where are we and where are we headed?","volume":"20","author":"Minciacchi","year":"2017","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ymeth.2020.02.003_b0210","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/sj.bjc.6605058","article-title":"Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer","volume":"100","author":"Nilsson","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ymeth.2020.02.003_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037279","article-title":"Biochemical and physical characterisation of urinary nanovesicles following CHAPS treatment","volume":"7","author":"Musante","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymeth.2020.02.003_b0220","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/14789450.2017.1392244","article-title":"Best practice of identification and proteomic analysis of extracellular vesicles in human health and disease","volume":"14","author":"S\u00f3dar","year":"2017","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.ymeth.2020.02.003_b0225","doi-asserted-by":"crossref","first-page":"26913","DOI":"10.3402\/jev.v3.26913","article-title":"Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles","volume":"3","author":"L\u00f6tvall","year":"2014","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0230","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.4185","article-title":"EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research","volume":"14","author":"Van Deun","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ymeth.2020.02.003_b0235","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0240","doi-asserted-by":"crossref","first-page":"30087","DOI":"10.3402\/jev.v4.30087","article-title":"Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper","volume":"4","author":"Lener","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0245","doi-asserted-by":"crossref","DOI":"10.1111\/trf.12281","article-title":"Biospecimen reporting for improved study quality (BRISQ)","volume":"53","author":"Moore","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.ymeth.2020.02.003_b0250","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ebiom.2019.09.025","article-title":"Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma","volume":"48","author":"Jones","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymeth.2020.02.003_b0255","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7150\/thno.18133","article-title":"Progress in exosome isolation techniques","volume":"7","author":"Li","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ymeth.2020.02.003_b0260","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2012.00162","article-title":"Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles","volume":"3","author":"Momen-Heravi","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymeth.2020.02.003_b0265","doi-asserted-by":"crossref","first-page":"1481321","DOI":"10.1080\/20013078.2018.1481321","article-title":"Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing","volume":"7","author":"Buschmann","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0270","doi-asserted-by":"crossref","first-page":"32945","DOI":"10.3402\/jev.v5.32945","article-title":"Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey","volume":"5","author":"Gardiner","year":"2016","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0275","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cell.2019.03.024","article-title":"Small RNA sequencing across diverse biofluids identifies optimal methods for exRNA isolation","volume":"177","author":"Srinivasan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ymeth.2020.02.003_b0280","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/ar389","article-title":"Autoantibodies directed to novel components of the PM\/Scl complex, the human exosome","volume":"4","author":"Brouwer","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.ymeth.2020.02.003_b0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fonc.2014.00129","article-title":"Analysis of extracellular RNA by digital PCR","volume":"4","author":"Takahashi","year":"2014","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ymeth.2020.02.003_b0290","doi-asserted-by":"crossref","unstructured":"L. Moldovan, K. Batte, Y. Wang, J. Wisler, M. Piper, Analyzing the Circulating MicroRNAs in Exosomes\/Extracellular Vesicles from Serum or Plasma by qRT-PCR. in Circulating MicroRNAs: Methods and Protocols (ed. Kosaka, N.) 129\u2013145 (Humana Press, 2013).","DOI":"10.1007\/978-1-62703-453-1_10"},{"key":"10.1016\/j.ymeth.2020.02.003_b0295","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fchem.2019.00279","article-title":"Nanoplasmonic approaches for sensitive detection and molecular characterization of extracellular vesicles","volume":"7","author":"Rojalin","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.ymeth.2020.02.003_b0300","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1021\/acsnano.7b08199","article-title":"Integrated analysis of exosomal protein biomarkers on alternating current electrokinetic chips enables rapid detection of pancreatic cancer in patient blood","volume":"12","author":"Lewis","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymeth.2020.02.003_b0305","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s12276-019-0218-2","article-title":"Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology","volume":"51","author":"Bandu","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ymeth.2020.02.003_b0310","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202773","article-title":"Nanoplasmonic pillars engineered for single exosome detection","volume":"13","author":"Raghu","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymeth.2020.02.003_b0315","doi-asserted-by":"crossref","first-page":"1587567","DOI":"10.1080\/20013078.2019.1587567","article-title":"Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material","volume":"8","author":"G\u00f6rgens","year":"2019","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.ymeth.2020.02.003_b0320","doi-asserted-by":"crossref","first-page":"1702153","DOI":"10.1002\/smll.201702153","article-title":"Biological functions and current advances in isolation and detection strategies for exosome nanovesicles","volume":"14","author":"Boriachek","year":"2018","journal-title":"Small"},{"key":"10.1016\/j.ymeth.2020.02.003_b0325","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1021\/acs.langmuir.5b01402","article-title":"Observations of tunable resistive pulse sensing for exosome analysis: improving system sensitivity and stability","volume":"31","author":"Anderson","year":"2015","journal-title":"Langmuir"},{"key":"10.1016\/j.ymeth.2020.02.003_b0330","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1586\/epr.09.17","article-title":"Exosomes: proteomic insights and diagnostic potential","volume":"6","author":"Simpson","year":"2009","journal-title":"Expert Rev. Proteomics"},{"key":"10.1016\/j.ymeth.2020.02.003_b0335","doi-asserted-by":"crossref","DOI":"10.1063\/1.5087122","article-title":"Challenges and opportunities in exosome research-perspectives from biology, engineering, and cancer therapy","volume":"3","author":"Li","year":"2019","journal-title":"APL Bioeng."},{"key":"10.1016\/j.ymeth.2020.02.003_b0340","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.apsb.2016.02.001","article-title":"Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges","volume":"6","author":"Ha","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ymeth.2020.02.003_b0345","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/cyto.a.22255","article-title":"A trigger channel threshold artifact in nanoparticle analysis","volume":"83","author":"Nolan","year":"2013","journal-title":"Cytometry A"},{"key":"10.1016\/j.ymeth.2020.02.003_b0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/cyto.a.22795","article-title":"Analytical challenges of extracellular vesicle detection: A comparison of different techniques","volume":"89","author":"Erdbr\u00fcgger","year":"2016","journal-title":"Cytometry A"},{"key":"10.1016\/j.ymeth.2020.02.003_b0355","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1373\/clinchem.2016.254649","article-title":"Waste, leaks, and failures in the biomarker pipeline","volume":"63","author":"Ioannidis","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymeth.2020.02.003_b0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PLoS Med."},{"key":"10.1016\/j.ymeth.2020.02.003_b0365","unstructured":"Center for Devices & Radiological Health. Overview of IVD Regulation."},{"key":"10.1016\/j.ymeth.2020.02.003_b0370","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamaoncol.2016.0097","article-title":"A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy","volume":"2","author":"McKiernan","year":"2016","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.ymeth.2020.02.003_b0375","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.eururo.2018.08.019","article-title":"A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate cancer in patients with prostate-specific antigen 2\u201310 ng\/ml at initial biopsy","volume":"74","author":"McKiernan","year":"2018","journal-title":"Eur. Urol."}],"container-title":["Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202319303135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046202319303135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:37:57Z","timestamp":1760924277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046202319303135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":75,"alternative-id":["S1046202319303135"],"URL":"https:\/\/doi.org\/10.1016\/j.ymeth.2020.02.003","relation":{},"ISSN":["1046-2023"],"issn-type":[{"value":"1046-2023","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From laboratory to clinic: Translation of extracellular vesicle based cancer biomarkers","name":"articletitle","label":"Article Title"},{"value":"Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymeth.2020.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}